ProShare Advisors
LAB icon

ProShare Advisors’s Standard BioTools LAB Stock Holding History

ProShare Advisors’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-41,674
Closed -$38.3K – 1971
2026
Q1 		$38.3K Sell
41,674
-13,034
-24% -$15.8K ﹤0.01% 1805
2025
Q4 		$70K Buy
54,708
+3,525
+7% +$4.74K ﹤0.01% 1915
2025
Q3 		$66.5K Sell
51,183
-10,197
-17% -$13.4K ﹤0.01% 1900
2025
Q2 		$73.7K Sell
61,380
-2,479
-4% -$2.75K ﹤0.01% 1932
2025
Q1 		$69K Sell
63,859
-19,215
-23% -$27K ﹤0.01% 1907
2024
Q4 		$145K Buy
83,074
+27,334
+49% +$50.9K ﹤0.01% 1976
2024
Q3 		$108K Buy
+55,740
New +$109K ﹤0.01% 1868
2022
Q2 		– Sell
-14,283
Closed -$51K – 1971
2022
Q1 		$51K Sell
14,283
-2,363
-14% -$8.16K ﹤0.01% 2114
2021
Q4 		$65K Buy
+16,646
New +$77.9K ﹤0.01% 2254
2021
Q3 		– Sell
-19,453
Closed -$120K – 2138
2021
Q2 		$120K Sell
19,453
-315
-2% -$1.68K ﹤0.01% 2267
2021
Q1 		$89K Buy
19,768
+3,377
+21% +$18.5K ﹤0.01% 2178
2020
Q4 		$98K Buy
+16,391
New +$108K ﹤0.01% 1992
2015
Q2 		– Sell
-5,422
Closed -$228K – 1721
2015
Q1 		$228K Sell
5,422
-604
-10% -$23.9K ﹤0.01% 1652
2014
Q4 		$203K Sell
6,026
-5,120
-46% -$145K ﹤0.01% 1733
2014
Q3 		$273K Sell
11,146
-2,529
-18% -$71.1K ﹤0.01% 1771
2014
Q2 		$402K Sell
13,675
-12,059
-47% -$386K 0.01% 1725
2014
Q1 		$1.13M Buy
+25,734
New +$1.13M 0.01% 1199
2013
Q4 		– Sell
-16,059
Closed -$352K – 1613
2013
Q3 		$352K Buy
16,059
+244
+2% +$4.79K 0.01% 1763
2013
Q2 		$276K Buy
+15,815
New +$278K 0.01% 1790

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

ProShare Advisors's LAB Position: Q2 2026 in Review

ProShare Advisors sold out of Standard BioTools (LAB) in Q2 2026, closing a stake of 41,674 shares — an estimated $38.3K sold.

ProShare Advisors first reported a position in LAB in Q2 2013 and held it in 19 quarters. The position peaked at $1.13M in Q1 2014. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • ProShare Advisors reported no remaining Standard BioTools position as of Q2 2026 after selling out during the quarter.
  • ProShare Advisors sold 41,674 Standard BioTools shares in Q2 2026, an estimated $38.3K.
  • ProShare Advisors first reported a position in Standard BioTools in Q2 2013 and held it in 19 quarters.
  • ProShare Advisors's Standard BioTools position peaked at $1.13M in Q1 2014.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.